Search

7 May 2024: ONETEPOrder-N Electronic Total Energy Package. ONETEP (Order-N Electronic Total Energy Package) is a linear-scaling code for quantum-mechanical calculations based on density-functional theory.Licensing Options:. ONETEP is available on an academic

7 May 2024: ISOLDEBuilding High Quality Macromolecular Models into Low Resolution ExperimentalMaps. ISOLDE is a ChimeraX plugin (installable via its built-in Tool Shed) designed to ease the task ofbuilding high quality macromolecular models into low to medium

7 May 2024: StradviewStradview is a visualisation and analysis package for 3D imaging data. Stradview uses novel algorithms to produce:. High quality surface modelsVolume and surface based visualisations (including movies using scripts)Cortical bone

7 May 2024: Clari-FiClari-Fi uses blurring to simulate the challenges of viewing small icons, imagesand text on mobile screens. Ideas to Reality: Clari-Fi from Cambridge Enterprise on Vimeo. Clari-Fi helps to evaluate the visual clarity (i.e. perceptibility) of

7 May 2024: CamSol Method. Key Features:. Rational design of protein variants with enhanced solubility.Fast solubility screening of protein libraries.Identification of aggregation-promoting hotspots. The CamSol Method is available for commercial and academic

7 May 2024: KARPAS 299 Lymphoma Cell LineHuman Non-Hodgkin's Ki-positive Large Cell Lymphoma cell lines. KARPAS 299 Human Non-Hodgkin’s Ki-positive Large Cell Lymphoma cell line useful inoncology research, developed at the University of Cambridge. Cambridge

7 May 2024: CAM2 hearing aid fitting softwareCAM2 software is a package that enables hearing aids to be tailored to anindividual’s needs, resulting in improved hearing quality. All modern hearing aids include multi-channel amplitude compression and the

7 May 2024: KARPAS 417 Human Myeloma cell line. KARPAS 417 Human Myeloma cell line useful in oncology research, developed at the Universityof Cambridge. Cambridge Enterprise Limited is the exclusive licensor for the Karpas cell line portfolio. Wehave partnered

7 May 2024: KARPAS 929 Human Myeloma cell line. KARPAS 929 Human Myeloma cell line, developed at the University of Cambridge, useful inoncology research. Cambridge Enterprise Limited is the exclusive licensor for the Karpas cell line portfolio. Wehave partnered

7 May 2024: KARPAS 1272 Human Myeloma cell line. KARPAS 1272 Human Myeloma cell line useful in oncology research, developed at theUniversity of Cambridge. Cambridge Enterprise Limited is the exclusive licensor for the Karpas cell line portfolio. Wehave

7 May 2024: KARPAS 707H Human Myeloma cell line. KARPAS 707H Human myeloma cell line suitable for the generation of stable humanhybridomas for the creation of fully human monoclonal antibodies. Cambridge Enterprise Limited is the exclusive licensor for the

7 May 2024: Human CD7 monoclonal antibody YTH30.15. Hybridoma cell line producing YTH 30.15 antibodies raised against human CD7 which are ratmonoclonal antibodies of the IgG2b isotype.

7 May 2024: Human CD59 monoclonal antibody YTH53.1. Hybridoma cell line producing YTH 53.1 antibodies raised against human CD59 which are ratmonoclonal antibodies of the IgG2b isotype. https://licensing.enterprise.cam.ac.uk/product/human-cd59-monoclonal-antibody

7 May 2024: Rat CD45 monoclonal antibody YTH 24.5. Hybridoma cell line producing YTH 24.5 antibodies raised against human CD45 which are ratmonoclonal antibodies of the IgG2b isotype. AuthorsHerman Waldmann. ReferencesC I Bindon, G Hale, M Clark, H

7 May 2024: Human CD11a monoclonal antibody YTH81.5. Hybridoma cell line producing YTH 81.5 antibodies raised against human CD11a which are ratmonoclonal antibodies of the IgG2a isotype.

7 May 2024: Mouse CD71 monoclonal antibody YTA74.4.4. Hybridoma cell line producing YTA 74.4.4 antibodies raised against mouse CD71 which aremonoclonal antibodies of the IgG2a isotype. Has been used in CD4 subset depletion in vivoand flow cytometry studies.

7 May 2024: Human CD28 monoclonal antibody YTH913.12. Hybridoma cell line producing YTH 913.12 antibodies raised against human CD28 which are ratmonoclonal antibodies of the IgG2b isotype.

7 May 2024: Human CD235a monoclonal antibody YTH89.1. Hybridoma cell line producing YTH 89.1 antibodies raised against human CD235a which are ratmonoclonal antibodies of the IgG2b isotype. AuthorsHerman Waldmann.

7 May 2024: Mouse CD18 monoclonal antibody YTS213.1.1. Hybridoma cell line producing YTS 213.1.1 antibodies raised against mouse CD18 which are ratmonoclonal antibodies of the IgG2a isotype. AuthorsHerman Waldmann.

7 May 2024: Rat IgG2b monoclonal antibody NORIg7.16.2. Hybridoma cell line against rat IgG2b, producing NORIg 7.16.2 antibodies which are mousemonoclonal antibodies. AuthorsHerman Waldmann. ReferencesG Hale; M Clark; H Waldmann(1 May

7 May 2024: KARPAS 241 Human Monoblastic cell line. KARPAS 241 Human Monoblastic cell line useful in oncology research, developed at theUniversity of Cambridge. Cambridge Enterprise Limited is the exclusive licensor for the Karpas cell line portfolio. Wehave

7 May 2024: Human CD45R monoclonal antibody YTH80.103. Hybridoma cell line producing YTH 80.103 antibodies raised against human CD45R which arerat monoclonal antibodies of the IgG2b isotype. AuthorsHerman Waldmann. ReferencesG Hale; M Clark; H Waldmann(May 1st

7 May 2024: Mouse Thy-1 monoclonal antibody YBM29.2.1. Hybridoma cell line producing YBM 29.2.1antibodies raised against mouse Thy-1, which are ratmonoclonal antibodies of the IgG2c isotype. This has been used in flow cytometry and in vitroT cell depletion

7 May 2024: FcgRlla 131R receptor expressing cell line. CHO cells transfected to express human FcgRlla allotype 131R as a transmembrane proteinwith its native intracellular domain. Useful for investigation of the binding of recombinantantibodies to human Fc

7 May 2024: FcgRlla 131H receptor expressing cell line. CHO cells transfected to express human FcgRlla allotype 131H as a transmembrane proteinwith its native intracellular domain. Useful for investigation of the binding of recombinantantibodies to human Fc

7 May 2024: Mouse Thy-1 monoclonal antibody YTS154.7.7.10. Hybridoma cell line producing YTS 154.7.7.10 antibodies raised against mouse Thy-1 which arerat monoclonal antibodies of the IgG2b isotype. Has been used in TNK cell depletion in vivoand flow cytometry

7 May 2024: FcgRIIIa 158F/GPI receptor expressing cellline. CHO cells transfected to express human FcgRIIIa of the 158F allotype on their surface asglycosyl-phosphatidylinositol-anchored molecules useful for investigation of the binding ofrecombinant antibodies

7 May 2024: Brief Early Skills & Support Index (BESSI)A promising teacher/nursery staff screening tool. The Brief Early Skills & Support Index (BESSI) questionnaire has been developed by Prof ClaireHughes and her colleagues at the University of Cambridge and

7 May 2024: JBIG-KIT Lossless Image CompressionLibraryJBIG-KIT, by Markus Kuhn, is a software implementation of the JBIG1 datacompression standard (ITU-T T.82), which was designed for bi-level high-resolution image data such as scanned documents. This library

7 May 2024: KARPAS 45 Human B-cell Leukaemia celllineHuman T-Cell Leukemia cell line useful in oncology research. Cambridge Enterprise Limited is the exclusive licensor for the Karpas cell line portfolio. Wehave partnered with ECACC (The European Collection of

7 May 2024: KARPAS 1718 Human Splenic Lymphomacell lineKARPAS 1718 Human Splenic Lymphoma cell line useful in oncology research,developed at the University of Cambridge. Cambridge Enterprise Limited is the exclusive licensor for the Karpas cell line portfolio.

7 May 2024: FcgRIIIa 158V/GPI receptor expressingcell line. CHO cells transfected to express human FcgRIIIa of the 158V allotype on their surface asglycosyl-phosphatidylinositol-anchored molecules useful for investigation of the binding ofrecombinant antibodies

7 May 2024: KARPAS 353 Human B-cell Leukaemia celllineKARPAS 353 Human B-cell Leukaemia cell line useful in oncology research,developed at the University of Cambridge. Cambridge Enterprise Limited is the exclusive licensor for the Karpas cell line portfolio.

7 May 2024: Human HLA-class I monoclonal antibodyYTH 862.2. Hybridoma cell line producing YTH 862.2 antibodies raised against human HLA-class I whichare rat monoclonal antibodies of the IgG2b isotype. AuthorsHerman Waldmann.

7 May 2024: Mouse CD8 (lyt-3) monoclonal antibodyYTS 156.7.7. Hybridoma cell line producing YTS 156.7.7 antibodies raised against mouse CD8 (lyt-3) whichare rat monoclonal antibodies of the IgG2b isotype. Has been used in CD8 subset depletion invivo and flow

7 May 2024: Sharp graphite tips for nanotechnologyapplications. Sharp graphite tips have been developed in the lab of Dr Amalio Fernandez-Pacheco at theUniversity of Cambridge using a three-step polishing method. The final diameter of the tips isless than 5

7 May 2024: Tetrabutylammonium (4’methyl-[2,2’bipyridin]-5yl)methanesulfonate. Tetrabutylammonium (4’methyl-[2,2’bipyridin]-5yl)methanesulfonate is a small molecule thathas been shown to act as a bifunctional ligand for iridium to control

7 May 2024: Mouse CD8 (lyt-2) monoclonal antibodyYTS 105.18.10. Hybridoma cell line producing YTS 105.18.10 antibodies raised against mouse CD8 (lyt-2)which are rat monoclonal antibodies of the IgG2a isotype.

7 May 2024: Mouse CD4 epitope B monoclonalantibody YTA 3.1.2. Hybridoma cell line producing YTA 3.1.2 antibodies raised against mouse CD4 Epitope B whichare rat monoclonal antibodies of the IgG2b isotype. Has been used in CD4 subset depletion invivo and flow

7 May 2024: KARPAS 231 Human B-cell Leukaemia celllineKARPAS 231 Human B-cell Leukaemia cell line useful in oncology research,developed at the University of Cambridge. Cambridge Enterprise Limited is the exclusive licensor for the Karpas cell line portfolio.

7 May 2024: Sheep immunoglobulin G monoclonalantibody SIg 375. Hybridoma cell line producing SIg 375 antibodies raised against sheep immunoglobulin Gwhich are mouse monoclonal antibodies of the IgG isotype. Has been used in western blots,affinity chromatography

7 May 2024: KARPAS 620 Human Plasma CellLeukaemia cell lineKARPAS 620 Human Plasma Cell Leukemia cell line useful in oncologyresearch. KARPAS 620 Human Plasma Cell Leukemia cell line useful in oncology research, developed atthe University of Cambridge.

7 May 2024: Mouse CD4 epitope A monoclonalantibody YTS 177.9.6.1. Hybridoma cell line producing YTS 177.9.6.1 antibodies raised against mouse CD4 epitope Awhich are rat monoclonal antibodies of the IgG2a isotype.

7 May 2024: Mouse heat stable antigen monoclonalantibody YBM 5.10.4. Hybridoma cell line producing YBM 5.10.4 antibodies raised against mouse heat stable antigenwhich are rat monoclonal antibodies of the IgG2c isotype. AuthorsHerman Waldmann. ReferencesG Hale;

7 May 2024: Human insulin receptor monoclonalantibody IR 18-34. Hybridoma cell line producing IR 18-34 antibodies raised against the extracellular domain ofthe human insulin receptor which are mouse monoclonal antibodies of the IgG2a isotype. Hasbeen shown to

7 May 2024: KARPAS 384 Human T-cell non-Hodgkin’sLymphoma cell lineKARPAS 384 Human T-cell non-Hodgkin’s Lymphoma cell line useful inoncology research, developed at the University of Cambridge. Cambridge Enterprise Limited is the exclusive licensor for the

7 May 2024: KARPAS 422 Human B-cell Non-Hodgkin’sLymphoma Cell LineKARPAS 422 Human B-cell Non-Hodgkin’s Lymphoma cell line useful inoncology research, developed at the University of Cambridge. Cambridge Enterprise Limited is the exclusive licensor for the

7 May 2024: KARPAS 1106P Human B-cell Non-Hodgkin’s Lymphoma cell lineKARPAS 1106P Human B-cell Non-Hodgkin’s Lymphoma cell line useful inoncology research, developed at the University of Cambridge. A human B-cell lymphoma established from a pleural

7 May 2024: Human Leukocyte Antigen B (HLA-B)monoclonal antibody YTH 76.3. Hybridoma cell line producing YTH 76.3 antibodies raised against human leukocyte antigen B(HLA-B) which are rat monoclonal antibodies of the IgG2a isotype. AuthorsHerman Waldmann.

7 May 2024: Rat insulin receptor substrate-1monoclonal antibody IRS 8-63. Hybridoma cell line producing IRS 8-63 antibodies raised against rat insulin receptor substrate-1 which are mouse monoclonal antibodies of the IgG1 isotype. Has been used